These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 6127911)

  • 1. Immunological approach to the pathogenetical role of Escherichia coli adhesive factor "119" in a suckling mouse urinary tract model.
    Kétyi I
    Acta Microbiol Acad Sci Hung; 1982; 29(2):123-7. PubMed ID: 6127911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adhesion inhibition by antibodies.
    Svanborg-Edén C; Mårild S; Korhonen TK
    Scand J Infect Dis Suppl; 1982; 33():72-8. PubMed ID: 6127804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against experimental pyelonephritis by antibodies to pili.
    Silverblatt FJ; Weinstein R; Rene P
    Scand J Infect Dis Suppl; 1982; 33():79-82. PubMed ID: 6127805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli.
    Billips BK; Yaggie RE; Cashy JP; Schaeffer AJ; Klumpp DJ
    J Infect Dis; 2009 Jul; 200(2):263-72. PubMed ID: 19522648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic immunization with conserved pilus-associated adhesins protects against mucosal infections.
    Palaszynski S; Pinkner J; Leath S; Barren P; Auguste CG; Burlein J; Hultgren S; Langermann S
    Dev Biol Stand; 1998; 92():117-22. PubMed ID: 9554264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suckling mouse model of urinary tract infections caused by Escherichia coli.
    Kétyi I
    Acta Microbiol Acad Sci Hung; 1981; 28(4):393-9. PubMed ID: 6119007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection.
    Fischer H; Yamamoto M; Akira S; Beutler B; Svanborg C
    Eur J Immunol; 2006 Feb; 36(2):267-77. PubMed ID: 16385628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoprotection of guinea pigs against experimental acute pyelonephritis after the administration of Escherichia coli purified fimbriae.
    Dima VF; Petrovici A; Dima SV; Petrovici M; Burghelea B
    Arch Roum Pathol Exp Microbiol; 1989; 48(3):215-25. PubMed ID: 2577515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of pili in the adhesion of Escherichia coli to human urinary tract epithelial cells.
    Korhonen TK; Väisänen V; Kallio P; Nurmiaho-Lassila EL; Ranta H; Siitonen A; Elo J; Svenson SB; Svanborg-Edén C
    Scand J Infect Dis Suppl; 1982; 33():26-31. PubMed ID: 6127801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of oral and combined parenteral/oral immunization against an experimental Escherichia coli urinary tract infection in mice.
    Layton GT; Smithyman AM
    Clin Exp Immunol; 1983 Nov; 54(2):305-12. PubMed ID: 6360434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance of broiler chickens to Escherichia coli respiratory tract infection induced by passively transferred egg-yolk antibodies.
    Kariyawasam S; Wilkie BN; Gyles CL
    Vet Microbiol; 2004 Mar; 98(3-4):273-84. PubMed ID: 15036536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenetic aspects of uncomplicated urinary tract infection: recent advances.
    Fünfstück R; Smith JW; Tschäpe H; Stein G
    Clin Nephrol; 1997 Jan; 47(1):13-8. PubMed ID: 9021235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [P-fimbriated Escherichia coli and serum antibody responses to P-fimbriae in pregnant women with urinary tract infections and their children].
    Miyazawa H; Yamaguchi M
    Nihon Jinzo Gakkai Shi; 1989 Mar; 31(3):293-9. PubMed ID: 2567787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urinary tract infections and their prevention].
    González-Chamorro F; Palacios R; Alcover J; Campos J; Borrego F; Dámaso D
    Actas Urol Esp; 2012 Jan; 36(1):48-53. PubMed ID: 21757260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of protective immunity after escherichia coli bladder infection in primates. Dependence of the globoside-specific P-fimbrial tip adhesin and its cognate receptor.
    Söderhäll M; Normark S; Ishikawa K; Karlsson K; Teneberg S; Winberg J; Möllby R
    J Clin Invest; 1997 Jul; 100(2):364-72. PubMed ID: 9218513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P fimbria-specific B cell responses in patients with urinary tract infection.
    Kantele A; Möttönen T; Ala-Kaila K; Arvilommi HS
    J Infect Dis; 2003 Dec; 188(12):1885-91. PubMed ID: 14673769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary tract infectivity or R strains of Escherichia coli carrying various virulence factors.
    Kétyi I; Naumann G; Nimmich W
    Acta Microbiol Hung; 1983; 30(2):155-61. PubMed ID: 6140809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
    Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
    Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relation between the O:K:H serotype and the fimbria antigen in E. coli of urinary tract infections].
    Nimmich W; Zingler G
    Z Urol Nephrol; 1984 Jun; 77(6):343-9. PubMed ID: 6206664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiology. Pods invade infected bladders.
    Ferber D
    Science; 2003 Jul; 301(5629):31. PubMed ID: 12843366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.